Zion Medical

Destruction of Cells Infected with HIV or Cancer

Health Tech & Life Sciences
Non Active, Oct 2021 ceased to operate

Company Overview

Snapshot

Founded in September 2014, Zion Medical operates with 1–10 employees. The company is in the Pre-Funding stage and ceased operations in October 2021. In October 2018, Zion Medical announced the results of its first human clinical trial for its HIV drug, Gammora, highlighting its potential as a cure.

Business overview

Zion Medical is a scientific research company focused on AIDS and cancer research within the Health Tech & Life Sciences sector. The company developed Gammora, an experimental drug that utilizes peptides derived from HIV to induce self-destruction (apoptosis) in infected cells. It also explores lentivirus manipulation for cancer therapy. Zion Medical operates in the Pharmaceuticals sector, targeting patients in the healthcare and life sciences markets.

Strategic signal

In October 2018, Zion Medical announced the results of its first human clinical trial for its HIV drug, Gammora, which demonstrated the drug's ability to promote self-induced death in HIV-infected cells. This milestone indicated significant progress in the development of a potential cure for HIV, signaling to investors the company's scientific validation and the potential for a breakthrough in infectious disease treatment.

Company Intelligence Q&A

What is Zion Medical's primary focus?
Zion Medical is primarily focused on scientific research in the fields of AIDS and cancer, developing experimental drugs to target infected cells.
What is Gammora?
Gammora is an investigational medicinal product developed by Zion Medical. It is a synthetic peptide compound derived from the HIV enzyme integrase, designed to stimulate the self-destruction of HIV-infected cells.
When did Zion Medical announce the results of its first human clinical trial for Gammora?
Zion Medical announced the results of its first human clinical trial for the HIV drug Gammora in October 2018.
Did Zion Medical explore other applications for its technology?
Yes, in May 2020, news reports indicated that the Israeli HIV drug developed by Zion Medical, Gammora, showed potential in easing COVID-19 symptoms in some HIV patients, suggesting broader applications for its technology.
When did Zion Medical cease operations?
Zion Medical ceased to operate in October 2021.

External links